[Clinical experience of latamoxef in the field of neurosurgery on the penetration into the cerebrospinal fluid in the patients with postoperative meningitis]

Jpn J Antibiot. 1985 Dec;38(12):3464-70.
[Article in Japanese]

Abstract

Latamoxef (LMOX) at a dose of 2 g was intravenously administered to 12 cases with postoperative meningitis and the concentrations in serum and cerebrospinal fluid (CSF) were examined up to 2 hours and the results obtained were as follows; The average serum and CSF concentrations of LMOX were 125.0 micrograms/ml, 4.33 micrograms/ml at 0.5 hour, 80.7 micrograms/ml, 4.64 micrograms/ml at 1 hour and 45.8 micrograms/ml, 3.82 micrograms/ml at 2 hours, respectively. The clinical responses of LMOX against postoperative meningitis were revealed excellent in 4 cases and good in 8 cases. No side effects were observed. LMOX was thought to be effective agent in the treatment of the postoperative meningitis.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Meningitis / cerebrospinal fluid*
  • Meningitis / drug therapy
  • Middle Aged
  • Moxalactam / administration & dosage
  • Moxalactam / blood
  • Moxalactam / cerebrospinal fluid*
  • Postoperative Complications

Substances

  • Moxalactam